551
Views
10
CrossRef citations to date
0
Altmetric
Drug Evaluation

Inotuzumab ozogamicin in B-cell acute lymphoblastic leukemias and non-Hodgkin’s lymphomas

, , , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Serengulam V. Govindan, Robert M. Sharkey & David M. Goldenberg. (2016) Prospects and progress of antibody-drug conjugates in solid tumor therapies. Expert Opinion on Biological Therapy 16:7, pages 883-893.
Read now
Jenny Dahl, Kayleigh Marx & Elias Jabbour. (2016) Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia. Expert Review of Hematology 9:4, pages 329-334.
Read now

Articles from other publishers (8)

Naresh Goli, Pradeep Kumar Bolla & Venu Talla. (2018) Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview. Journal of Drug Delivery Science and Technology 48, pages 106-117.
Crossref
Nikolas Stefan, Rémy Gébleux, Lorenz Waldmeier, Tamara Hell, Marie Escher, Fabian I. Wolter, Ulf Grawunder & Roger R. Beerli. (2017) Highly Potent, Anthracycline-based Antibody–Drug Conjugates Generated by Enzymatic, Site-specific Conjugation. Molecular Cancer Therapeutics 16:5, pages 879-892.
Crossref
Magali Guffroy, Hadi Falahatpisheh, Kathleen Biddle, John Kreeger, Leslie Obert, Karen Walters, Richard Goldstein, Germaine Boucher, Timothy Coskran, William Reagan, Danielle Sullivan, Chunli Huang, Sharon Sokolowski, Richard Giovanelli, Hans-Peter Gerber, Martin Finkelstein & Nasir Khan. (2017) Liver Microvascular Injury and Thrombocytopenia of Antibody–Calicheamicin Conjugates in Cynomolgus Monkeys—Mechanism and Monitoring. Clinical Cancer Research 23:7, pages 1760-1770.
Crossref
John M. Lambert. 2016. Antibody-Drug Conjugates. Antibody-Drug Conjugates 1 32 .
Dan Douer. (2016) Efficacy and Safety of Vincristine Sulfate Liposome Injection in the Treatment of Adult Acute Lymphocytic Leukemia. The Oncologist 21:7, pages 840-847.
Crossref
Aharon Ronson, Ariella Tvito & Jacob M. Rowe. (2016) Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults. Current Oncology Reports 18:6.
Crossref
Binsah George, Hagop Kantarjian, Elias Jabbour & Nitin Jain. (2016) Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia. Immunotherapy 8:2, pages 135-143.
Crossref
Christopher D. Thanos & Paul D. Rennert. 2016. Novel Immunotherapeutic Approaches to the Treatment of Cancer. Novel Immunotherapeutic Approaches to the Treatment of Cancer 181 201 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.